Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Theophylline in Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update indicates that theophylline trials in chronic obstructive pulmonary disease have completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: COPD | Phase 2, Phase 3 | Status: COMPLETED